Home/Filings/4/0001209191-23-018956
4//SEC Filing

KIDRON NADAV 4

Accession 0001209191-23-018956

CIK 0001176309other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 5:25 PM ET

Size

5.4 KB

Accession

0001209191-23-018956

Insider Transaction Report

Form 4
Period: 2023-03-14
KIDRON NADAV
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-03-14$2.01/sh+100,000$201,000100,000 total(indirect: By wholly-owned corporation)
Holdings
  • Common Stock

    1,053,098

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001351779

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:25 PM ET
Size
5.4 KB